BioSpace News Archive

Integral Molecular, an industry leader in developing antibodies against membrane proteins, announced that it entered into an exclusive worldwide antibody license agreement with AstraZeneca to develop therapeutics for multiple cancers.

The Geistlich Surgery, USA business unit of Geistlich Pharma AG, a family owned, Swiss-based global leader in regenerative solutions, is proud to announce the launch of its latest advancement: Geistlich Nexo-Gide® Dual Surface Membrane.

Ottobock, a leading global innovator for prosthetics, orthotics, and exoskeletons, today announced the acquisition of 100 percent of the shares of suitX

Innovia Medical (“Innovia”) has partnered with Lacrimedics, Inc. (“Lacrimedics”).

Ventus Therapeutics is presenting data for its cyclic GMP-AMP synthase (cGAS) inhibitor program this month at two upcoming conferences: the 4th Inflammatory Skin Disease Summit (November 3-6, 2021) and the American College of Rheumatology Annual Meeting, ACR Convergence (November 5-9, 2021).

Kezar Life Sciences, Inc. today announced that it will host a virtual Investor and Analyst Day on November 15, 2021, at 4:30 p.m. ET.

Evoke Pharma, Inc. today announced that the Company is scheduled to release its third quarter 2021 financial results on Wednesday, November 10, 2021, after the market closes.

Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced that Jiangsu Hengrui Pharmaceuticals Co., Ltd (“Hengrui”) has completed its Phase 3 clinical study of oteseconazole (SHR8008) compared to fluconazole in subjects with acute vulvovaginal candidiasis (VVC).

Check-Cap Ltd. today announced financial results and provided a corporate update for the third quarter and nine months ended September 30, 2021.

PAVmed Inc., a highly differentiated, multi-product, commercial-stage medical device company, and its major subsidiary Lucid Diagnostics Inc., a cancer prevention medical diagnostics company announced that the companies will host a joint business update conference call on Tuesday, November 16, 2021, at 4:30 PM EDT.